Patents by Inventor Svitlana P. BONDARENKO

Svitlana P. BONDARENKO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cytisine-linked isoflavonoid antineoplastic agents for the treatment of cancer
    Patent number: 10188743
    Abstract: Cytisine-linked isoflavonoids, or pharmaceutically acceptable salts thereof or pharmaceutically acceptable compositions thereof, are useful for the treatment of conditions in which cells have a reliance on peroxisomal HSD17B4 to degrade very long chain fatty acids and provide necessary energy for cell proliferation, such as is seen in colorectal cancer and prostate cancer, for example.
    Type: Grant
    Filed: September 25, 2017
    Date of Patent: January 29, 2019
    Assignee: University of Kentucky Research Foundation
    Inventors: Chunming Liu, David S. Watt, Mykhaylo S. Frasinyuk, Vitaliy M. Sviripa, Wen Zhang, Svitlana P. Bondarenko
  • CYTISINE-LINKED ISOFLAVONOID ANTINEOPLASTIC AGENTS FOR THE TREATMENT OF CANCER
    Publication number: 20180344862
    Abstract: Cytisine-linked isoflavonoids, or pharmaceutically acceptable salts thereof or pharmaceutically acceptable compositions thereof, are useful for the treatment of conditions in which cells have a reliance on peroxisomal HSD17B4 to degrade very long chain fatty acids and provide necessary energy for cell proliferation, such as is seen in colorectal cancer and prostate cancer, for example.
    Type: Application
    Filed: September 25, 2017
    Publication date: December 6, 2018
    Inventors: Chunming LIU, David S. WATT, Mykhaylo S. FRASINYUK, Vitaliy M. SVIRIPA, Wen ZHANG, Svitlana P. BONDARENKO
  • 3-aryl-4H-chromene-4-ones as antineoplastic agents for the treatment of cancer
    Patent number: 9718799
    Abstract: Isoflavonoids or pharmaceutically acceptable salts thereof or pharmaceutically acceptable compositions thereof for the treatment of prostate cancer or for the treatment or inhibition of prostate cancer metastasis in a patient in need thereof are disclosed.
    Type: Grant
    Filed: May 9, 2016
    Date of Patent: August 1, 2017
    Assignee: University of Kentucky Research Foundation
    Inventors: Svitlana P. Bondarenko, Mykhaylo S. Frasinyuk, Chunming Liu, David S. Watt
  • 3-ARYL-4H-CHROMENE-4-ONES AS ANTINEOPLASTIC AGENTS FOR THE TREATMENT OF CANCER
    Publication number: 20160332981
    Abstract: Isoflavonoids or pharmaceutically acceptable salts thereof or pharmaceutically acceptable compositions thereof for the treatment of prostate cancer or for the treatment or inhibition of prostate cancer metastasis in a patient in need thereof are disclosed.
    Type: Application
    Filed: May 9, 2016
    Publication date: November 17, 2016
    Inventors: Svitlana P. BONDARENKO, Mykhaylo S. FRASINYUK, Chunming LIU, David S. WATT